Early study of HRS-4139 in healthy adults
Part of Skin clinical trials.
This trial studies an investigational medicine called HRS-4139 in healthy adults. The purpose is to see how safe it is, how the body processes it, and how it affects the immune system.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old.
- Your body mass index (BMI) must be between 18 and 26.
- You must be in good general health, with no significant medical conditions.
- You must not have taken any medications (including over-the-counter drugs, supplements, or herbal products) within 2 weeks before the study starts.
- You must not have received a live vaccine within the past month.
- You must not have participated in another clinical trial within the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational drug, called HRS-8797, in healthy people to see how safe it is and how the body processes it. It's an early-phase trial, so you may not directly benefit, but your participation can help find new treatments for future patients.
This is an early-stage safety test of a new experimental drug called HRS-5765 in people without serious health conditions. Researchers want to make sure the drug is safe and understand how your body processes it.
This is an early-stage safety study of an experimental drug called HRS-7156 in people with no serious health conditions. Researchers will monitor how your body tolerates the drug and how it moves through your system.
This study tests a new medication called HL40626S to see if it is safe in healthy adults. You would take the tablet and have regular checkups to monitor how your body responds.
This study tests the safety of a new oral medication called HRS-1597 in two groups: healthy people with normal weight and people who are overweight or obese. It will help determine if the drug is safe and how the body processes it.
This study tests a new investigational tablet in healthy adults to see how the body handles it and if it's safe. The results will help guide future research.
Hear when a new Psoriasis Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.